呼吸道与非呼吸道标本分离MRSA临床株耐药性比较及其分子流行病学特征

doi:10.13481/j.1671-587X.20240215

Abstract

Abstract:

Objective To discuss the differences in drug resistance， molecular typing， and biofilm-forming abilities of methicillin-resistant Staphylococcus aureus （MRSA） isolated from respiratory and non-respiratory tract specimens. Methods A total of 100 MRSA strains were selected from clinical specimens of the hospitalized patients， and 50 MRSA strains were isolated from the respiratory specimens and another 50 MRSA strains were isolated from non-respiratory tract specimens. These 100 MRSA strains underwent an in vitro susceptibility test for 14 kinds of antimicrobial drugs， molecular typing was performed through multilocus sequence typing （MLST） and Staphylococcus aureus protein A （Spa） typing， and their biofilm-forming abilities were detected by crystal violet staining assay. Results The in vitro susceptibility tests results showed that all the 100 MRSA strains had high overall resistance rates of over 60.0% to penicillin， erythromycin， clindamycin， levofloxacin， ciprofloxacin， moxifloxacin， and tetracycline， while only 9.0% exhibited resistance to trimethoprim-sulfamethoxazole， and all the strains were susceptible to vancomycin， linezolid， tigecycline， and quinupristin/dalfopristin. Compared with those isolated from non-respiratory tract specimens，the MRSA strains isolated from respiratory tract specimens showed significantly higher resistance rates to moxifloxacin， levofloxacin， ciprofloxacin， tetracycline， and gentamicin （P<0.05）. Among the 100 MRSA strains， 17 genotypes were identified， and the dominant types weve ST5-t2460 （26.0%）， ST239-t030 （23.0%）， and ST59-t437 （20.0%）. In the MRSA from the respiratory tract specimens， the dominant types were ST5-t2460 （20.0%） and ST239-t030 （13.0%）， followed by ST59-t437 （7.0%）； in the non-respiratory tract specimens， 13 genotypes were found， and the dominant types were ST59-t437 （13.0%） and ST239-t030 （10.0%）. All 100 MRSA strains were biofilm producers， among them the strong biofilm formers， moderate biofilm formers， and weak biofilm formers accounted for 2.0% （2/100）， 24.0% （24/100）， and 74.0% （74/100）， respectively. The ST59-t437 clones had overall strong biofilm-forming abilities， and 60.0% （12/20） stains were moderate to strong biofilm formers. Conclusion The MRSA strains isolated from the respiratory tract specimens have a significantly higher overall resistance rate than those isolated from the non-respiratory tract specimens. The ST59-t437 and ST239-t030 genotypes are dominant clones common to both types of specimens， and ST59-t437 strains show strong biofilm-forming abilities， and ST239-t030 strains exhibit the strongest resistance.

Key words: Methicillin-resistant Staphylococcus aureus, Drug resistance, Molecular typing, Biofilm

CLC Number:

R378.1

ERDEMUTU,Yanyan WANG,Yutong LI,Guilin CHEN,Junrui WANG. Comparison of drug resistance of MRSA clinical strains from respiratory tract and non-respiratory tract specimens and their molecular epidemiological characteristics[J].Journal of Jilin University(Medicine Edition), 2024, 50(2): 422-430.

Figures/Tables 4

Tab. 1

Tab. 2

Fig. 1

Tab. 3

References 30

1	CHALMERS S J， WYLAM M E. Methicillin-resistant Staphylococcus aureus infection and treatment options［J］. Methods Mol Biol， 2020，2069：229-251.
2	CANTY E， CARNAHAN B， CURLEY T， et al. Reduced vancomycin susceptibility， MRSA and treatment failure in pediatric staphylococcus aureus bloodstream infections［J］. Pediatr Infect Dis J， 2021， 40（5）： 429-433.
3	RANJBAR R， ALAM M. Antimicrobial Resistance Collaborators （2022）. Global burden of bacterial antimicrobial resistance in 2019： a systematic analysis［J］. Evid Based Nurs， 2023： ebnurs-eb2022-103540.
4	胡付品，郭燕，朱德妹，等. 2021年CHINET中国细菌耐药监测［J］. 中国感染与化疗杂志， 2022，22（5）：521-530.
5	申恩华，王立红，王辉，等.中国15个地区分离的耐甲氧西林金黄色葡萄球菌基因分型研究［J］.中华流行病学杂志，2010（3）：308-311.
6	陈泰尧，葛忆琳，刘雪薇，等.2017—2018年上海某医院耐甲氧西林金黄色葡萄球菌分子生物学特征研究［J］.中华预防医学杂志，2020，54（8）：849-853.
7	陈江华，顾向明，邓冲，等. 伤口与呼吸道医院感染金黄色葡萄球菌的耐药情况对比研究［J］. 中国抗生素杂志， 2012， 37（4）：3.
8	BONAVENTURA G D， POMPILIO A， MONACO M，et al. Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host： relationship with macrolide resistance and clonal lineages［J］. J Med Microbiol， 2019， 68（2）： 148-160.
9	POMORSKA-WESOŁOWSKA M， CHMIELARCZYK A， CHLEBOWICZ M， et al. Virulence and antimicrobial resistance of Staphylococcus aureus isolated from bloodstream infections and pneumonia in Southern Poland［J］. J Glob Antimicrob Resist， 2017， 11： 100-104.
10	李方去，杨锦红，王慧燕，等. 两种临床标本中耐甲氧西林的金黄色葡萄球菌生物膜形成能力的检测与其耐药特征的研究［J］. 中国微生态学杂志， 2012， 24（6）： 531-533.
11	Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S32 ［S］. Wayne，PA：CLSI，2022.
12	LAWAL O U， AYOBAMIY O， ABOUELFETOUH A，et al. A 6-year update on the diversity of methicillin-resistant Staphylococcus aureus clones in africa： A systematic review［J］. Front Microbiol，2022，3（13）：860436.
13	RAO Q， SHANG W L， HU X M， et al. Staphylococcus aureus ST121： a globally disseminated hypervirulent clone［J］. J Med Microbiol， 2015，64（12）： 1462-1473.
14	OGURA K， KAJI D， SASAKI M，et al.Predominance of ST8 and CC1/spa-t1784 methicillin-resistant staphylococcus aureus isolates in Japan and their genomic characteristics［J］.J Glob Antimicrob Resist， 2022， 28：195-202.
15	KIM Y K， EOM Y， KIM E， et al. Molecular characteristics and prevalence of rifampin resistance in Staphylococcus aureus isolates from patients with bacteremia in South Korea［J］. Antibiotics （Basel），2023，12（10）：1511.
16	CHONGTRAKOOL P， ITO T， MA X X， et al. Staphylococcal cassette chromosome mec （SCCmec） typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries： a proposal for a new nomenclature for SCCmec elements［J］. Antimicrob Agents Chemother， 2006， 50（3）： 1001-1012.
17	IP M， YUNG R W， NG T K， et al. Contemporary methicillin-resistant Staphylococcus aureus clones in Hong Kong［J］. J Clin Microbiol， 2005， 43（10）：5069-5073.
18	李文青，程锦娥，吴伟元，等. 深圳地区甲氧西林耐药金黄色葡萄球菌耐药性及分子流行病学特征［J］. 中国人兽共患病学报， 2017， 33（12）： 1098-1102.
19	DAI Y X， LIU J L， GUO W， et al. Decreasing methicillin-resistant Staphylococcus aureus （MRSA） infections is attributable to the disappearance of predominant MRSA ST239 clones， Shanghai， 2008-2017［J］. Emerg Microbes Infect， 2019， 8（1）： 471-478.
20	LI X， ZHANG J， ZHANG Y， et al. Methicillin-resistant Staphylococcus aureus of the clonal lineage ST5-SCCmecⅡ-t2460 was associated with high mortality in a Wuhan hospital［J］. Braz J Microbiol，2021， 52（4）：1929-1936.
21	WANG X， LI X， LIU W，et al. Molecular characteristic and virulence gene profiles of community-associated Methicillin-resistant Staphylococcus aureus isolates from pediatric patients in Shanghai， China［J］. Front Microbiol， 2016， 7： 1818.
22	LI X H， ZHANG J， ZHANG Y F， et al. Methicillin-resistant Staphylococcus aureus of the clonal lineage ST5-SCCmecⅡ-t2460 was associated with high mortality in a Wuhan hospital［J］. Braz J Microbiol， 2021， 52（4）： 1929-1936.
23	ZHANG H， QIN L， JIN C， et al. Molecular Characteristics and antibiotic resistance of Staphylococcus aureus isolated from patient and food samples in Shijiazhuang， China［J］. Pathogens， 2022，11（11）：1333.
24	OMUSE G， VAN ZYL K N， HOEK K，et al. Molecular characterization of Staphylococcus aureus isolates from various healthcare institutions in Nairobi， Kenya： a cross sectional study［J］. Ann Clin Microbiol Antimicrob， 2016， 15（1）： 51.
25	陆军，祝进，徐礼锋，等. 社区与医院获得性耐甲氧西林金黄色葡萄球菌耐药性分析与比较［J］. 中国卫生检验杂志， 2012， 22（2）：380-382.
26	CHEN Y， LIU Z X， DUO L B， et al. Characterization of Staphylococcus aureus from distinct geographic locations in China： an increasing prevalence of spa-t030 and SCCmec type Ⅲ［J］. PLoS One， 2014， 9（4）： e96255.
27	LI Y M， ZHAO R K， ZHANG X F， et al. Prevalence of enterotoxin genes and spa genotypes of methicillin-resistant Staphylococcus aureus from a tertiary care hospital in China［J］. J Clin Diagn Res， 2015， 9（5）： DC11-DC14.
28	李文婷，耿文静，姚开虎，等. 新生儿重症监护室金黄色葡萄球菌定植菌株的耐药性及生物膜形成能力研究［J］. 中国抗生素杂志， 2022， 47（3）： 289-294.
29	ZHANG C， LI Z， PAN Q， et al. Berberine at sub-inhibitory concentration inhibits biofilm dispersal in Staphylococcus aureus ［J］. Microbiology （Reading），2022，168（9）. DOI： 10.1099/mic.0.001243 . doi: 10.1099/mic.0.001243
30	BHATTACHARYA S， BIR R， MAJUMDAR T. Evaluation of multidrug resistant staphylococcus aureus and their association with biofilm production in a tertiary care hospital， Tripura， northeast India［J］. J Clin Diagn Res， 2015， 9（9）： DC01-DC04.

Antimicrobial drug	MRSA （n=100）	MRSA from respiratory tract specimen（n=50）		MRSA from non-respiratory tract specimen（n=50）		χ²	P
Antimicrobial drug	MRSA （n=100）	No.of drug-resistant strain(n)	Resistant rate(η/%)	No.of drug-resistant strain(n)	Resistant rate(η/%)	χ²	P
Vancomycin	0	0	0.0	0	0.	－	－
Tetracycline	0	0	0	0	0.	－	－
Rifampicin	25	15	30.0	10	20.0	0.853	0.356
Penicillin	100	50	100.0	50	100.0	－	－
Erythromycin	87	44	88.0	43	86.0	－	－
Clindamycin	73	38	76.0	34	68.0	0.446	0.504
Quinuptin / dafuptin	0	0	0.	0	0.	－	－
Tigecycline	0	0	0.	0	0.	－	－
Trimethoprim and sulphame-thoxazole	9	2	4.0	7	14.0	1.954	0.162
Moxifloxacin	62	40	80.0	22	44.0	12.270	0.001
Levofloxcin	70	43	86.0	27	54.0	10.710	0.001
Ciprofloxacin	70	43	86.0	27	54.0	10.710	0.001
Gentamycin	46	29	58.0	17	34.0	4.871	0.027
Tetracycline	70	44	88.0	26	52.0	13.760	<0.01

Antimicrobial resistance drug	ST5-t2460			ST239-t030			ST59-t437
Antimicrobial resistance drug	Total MRSA （n=26）	MRSA from respiratory tract （n=20）	MRSA from non-respiratory tract （n=6）	Total MRSA （n=23）	MRSA from respiratory tract （n=13）	MRSA from non-respiratory tract （n=10）	Total MRSA （n=20）	MRSA from respiratory tract （n=7）	MRSA from non-respiratory tract (n=13）
Levofloxcin	100.0	100.0	100.0	95.7	100.0	90.0	10.0	28.6	0.
Ciprofloxacin	100.0	100.0	100.0	95.7	100.0	90.0	10.0	28.6	0.
Moxifloxacin	100.0	100.0	100.0	95.7	100.0	90.0	10.0	28.6	0.
Erythromycin	100.0	100.0	100.0	78.3	69.2	90.0	95.0	100.0	92.3
Clindamycin	88.5	85.0	100.0	69.6	69.2	70.0	90.0	85.7	92.3
Tetracycline	100.0	100.0	100.0	95.7	100.0	90.0	55.0	71.4	46.2
Gentamycin	53.8	55.0	50.0	87.0	100.0	70.0	15.0	28.6	7.7
Rifampicin	3.9	5.0	0.	87.0	84.6	90.0	5.0	14.3	0.

[1]	Chunyan KANG,Xiuzhi ZHANG,Huicong ZHOU,Jie CHEN. Effect of downregulating proline-rich protein 11 expression on drug resistance of esophageal cancer drug resistant cell EC9706/DDP and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 113-119.
[2]	Xiaolu SHI,Ye TIAN,Shaobo ZHAI,Yang LIU,Shunli CHU. Preparation of PPC/PBS-based guided bone regeneration membrane and evaluation of its physiochemical properties and biological characteristics [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1473-1483.
[3]	Jiaojiao XUE,Lei HAO,Yuxiu ZHANG,Heyang DAI,Lixia ZHANG,Shaowei GUO,Jingjing ZHANG,Yang LI,Qingxia LI. Effect of Huaier aqueous extract on breast cancer tamoxifen-resistant LCC2 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 714-721.
[4]	Yanan MA,Bing TAN,Lei XU,Jiandong ZHANG. Detection of drug resistance genes of Acinetobacter baumannii in sputum samples of ICU patients by real-time fluorescence quantitative PCR method and its evaluation [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1623-1628.
[5]	Eerdemutu,Yanyan WANG,Yingying LYU,Guilin CHEN,Junrui WANG. Genotyping,antibiotic resistance, and biological characteristics of panton-valentine leukocidin gene-negative Staphylococcus aureus [J]. Journal of Jilin University(Medicine Edition), 2022, 48(4): 971-978.
[6]	Shunjia SONG,Xinying WANG,Feifei JIANG,Huijian JIA,Yuan ZHAO,Zhiping YANG,Liyuan SUN,Yundong ZHAO. Resistance rates of Helicobacter pylori to clarithromycin, metronidazole, and levofloxacin and mutation characteristics of their related drug resistance genes [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 630-637.
[7]	Qinghui WANG,Bo LI,Chuancui HU,Mingchao NIE,Xiaomei ZHENG. Effects of miR-107 on regulation of immune escape and taxol resistance of ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 734-743.
[8]	Peipei ZHANG,Donghui GAO,Yue TIAN,Hongyan LI. Effect of guided biofilm therapy for periodontitis in diabetic patient: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 493-499.
[9]	Lisong CHEN,Hui FANG,Hefei WANG,Chengyuan HE,Xiaodong GAI,Chun LI. Effects of Notch1 signaling pathway on invasion and cisplatin resistance of lung adenocarcinoma cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2021, 47(5): 1171-1177.
[10]	Xiulan YE, Ming LI, Zhaojian WANG, Haiyan ZHAO, Jianning MA, Jing LIU, Yi ZHENG, Shunqing LI, Yu ZHANG. Effects of Cornus officinalis polysaccharide on behavior and multidrug resistance gene 1b and major vault protein expressions in hippocampus tissue of refractory epilepsy young rats [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 644-651.
[11]	Aihua REN,Wan LIU,Dawei WANG. Influence of PD-L1 knockout based on CRISPR/Cas9 technology in gefitinib resistance sensitivity of PC-9/T790M in non-small cell lung cancer [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 292-298.
[12]	Guo HUANG,Youquan WANG,Juan CHEN. Reverse effect of miR-138-5p targeted inhibition of HIF-1α expression on cisplatin resistance of breast cancer MCF-7 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 360-368.
[13]	Guang YAO,Yuying LU,Qinghua ZHANG,Haixia ZHU,Yiwei CHEN,Dong SUN,Zhen ZHUANG,Feng ZHANG,Ding LIU,Zhi SONG. Genomic evolution and drug resistance analysis of human-derived Listeria monocytogenes [J]. Journal of Jilin University(Medicine Edition), 2021, 47(1): 180-186.
[14]	Ye LIU,Longyun CHEN. Effect of astragalus polysaccharide on cisplatin resistance of human lung cancer A549/DDP cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(6): 1162-1168.
[15]	LIU Dongning, YANG Mingxi, LIU Xinchan, LI Yan, WU Zhou, YU Weixian. Inhibitory effects of zinc-doped carbon dots combined with blue light radiation on growth and biofilm formation of Staphylococcus aureus [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 515-522.

Comparison of drug resistance of MRSA clinical strains from respiratory tract and non-respiratory tract specimens and their molecular epidemiological characteristics

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 30

Related Articles 15

Metrics

Comments

Recommended 0

Molecular charateristic				Source of sample		Biofilm-forming ability
STs	n	Spa	n	Respiratory tract	Non-respiratory tract	Respiratory tract			Non-respiratory tract
STs	n	Spa	n	Respiratory tract	Non-respiratory tract	+	?	?	+	?	?
ST5	26	t2460	26	20	6	15	5	0	4	2	0
ST239	25	t030	23	13	10	13	0	0	10	0	0
		t1493	1	1	0	1	0	0	0	0	0
		t4239	1	1	0	1	0	0	0	0	0
ST59	25	t437	20	7	13	2	4	1	6	6	1
		t2460	2	1	1	1	0	0	1	0	0
		t3590	1	0	1	0	0	0	1	0	0
		t441	1	0	1	0	0	0	1	0	0
		t7496	1	0	1	0	0	0	1	0	0
ST22	12	t005	9	1	8	0	1	0	6	2	0
		t309	2	0	2	0	0	0	1	1	0
		t2460	1	0	1	0	0	0	0	1	0
ST25	6	t078	5	2	3	2	0	0	2	1	0
ST25	6	t258	1	0	1	0	0	0	1	0	0
ST5939	2	t2460	2	2	0	2	0	0	0	0	0
ST398	1	t034	1	1	0	1	0	0	0	0	0
ST5637	1	t3622	1	0	1	0	0	0	0	1	0
ST5662	1	t2460	1	0	1	0	0	0	1	0	0
ST1	1	t127	1	1	0	1	0	0	0	0	0
Total	100		100	50	50	39	10	1	35	14	1